Product Information
RUKOBIA ER 600 MG TABLET is a brand product labeled by ViiV Healthcare Company, priced at $156.8362 per EA under NDC 49702025018. Its NADAC has been published 118 times since May 22, 2024.
FDA first approved this application on Jul 2, 2020.
Strength
600 mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702025018
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FOSTEMSAVIR TROMETHAMINEApproval Type
New Drug (NDA)
FDA Application
NDA212950FDA Approved
7/2/2020
On Market Since
7/2/2020
Price Statistics
The NADAC for RUKOBIA ER 600 MG TABLET has been published 118 times since May 22, 2024, and over the history we have for it it has risen 7.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $156.8362 per EA |
|---|---|
| All-time high | $156.8667 (Jul 15, 2026) |
| All-time low | $145.3305 (May 22, 2024) |
| 52-week high | $156.8667 |
| 52-week low | $149.8926 |
| Median price | $150.1749 |
| Average price | $150.7767 |
| Largest weekly change | +4.0% (Jan 7, 2026) |
| Weeks tracked | 118 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fostemsavir tromethamine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RUKOBIA ER 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RUKOBIA ER 600 MG TABLET, manufactured by ViiV Healthcare Company, is $156.8362 per EA (NDC 49702025018), effective Aug 19, 2026.
How has the price of RUKOBIA ER 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for RUKOBIA ER 600 MG TABLET has risen 7.9%. It has been tracked across 118 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for RUKOBIA ER 600 MG TABLET?
Since May 22, 2024, the NADAC for RUKOBIA ER 600 MG TABLET has ranged from a low of $145.3305 (May 22, 2024) to a high of $156.8667 (Jul 15, 2026), with a median of $150.1749 per EA.
Are there cheaper alternatives to RUKOBIA ER 600 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of RUKOBIA ER 600 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RUKOBIA ER 600 MG TABLET?
RUKOBIA ER 600 MG TABLET (NDC 49702025018) is labeled by ViiV Healthcare Company, and CMS classifies it as a brand product.